8-KShareholder Matters

CENTENE CORP 8-K Report, Shareholder Vote Results (May 15, 2023)

Filed May 15, 2023For Securities:CNC

Summary

Centene Corporation (CNC) filed an 8-K on May 15, 2023, detailing the results of its Annual Meeting of Stockholders held on May 10, 2023. The primary focus of this filing is the outcome of various shareholder votes. All ten director nominees were overwhelmingly elected, indicating strong shareholder confidence in the current board. Additionally, the company's executive compensation plan received a positive advisory vote, with a substantial majority of shareholders approving it. The frequency of future advisory votes on executive compensation was also overwhelmingly set to '1 Year', aligning with common corporate governance practices. Further demonstrating shareholder support for the company's governance and financial oversight, the appointment of KPMG LLP as the independent registered public accounting firm for fiscal year 2023 was ratified with a significant majority. However, two shareholder proposals, one concerning the ratification of termination pay and another on maternal morbidity reduction metrics in executive compensation, were not approved. These results suggest that while shareholders are generally supportive of Centene's leadership and compensation structure, they have rejected these specific governance and policy initiatives.

Key Highlights

  • 1All ten director nominees were elected for a one-year term with substantial support from shareholders.
  • 2The non-binding advisory vote on executive compensation was approved by a significant majority of shareholders.
  • 3Shareholders overwhelmingly voted for an annual frequency (1 Year) for future advisory votes on executive compensation.
  • 4The appointment of KPMG LLP as the independent registered public accounting firm for fiscal year 2023 was ratified by a large majority.
  • 5A shareholder proposal regarding the ratification of termination pay did not receive majority approval.
  • 6A shareholder proposal concerning maternal morbidity reduction metrics in executive compensation was not approved by shareholders.

Frequently Asked Questions

The Annual Meeting saw the election of all ten director nominees, the approval of the company's executive compensation plan through a non-binding advisory vote, and the ratification of KPMG LLP as the independent auditor. Shareholders also voted for an annual frequency for future advisory votes on executive compensation. However, two shareholder proposals, one on termination pay ratification and another on maternal morbidity metrics, were not approved.

Yes, shareholders approved Centene's executive compensation through a non-binding advisory vote. The proposal received a 'For' vote of 408,119,178, indicating substantial support.

Shareholders voted overwhelmingly to have advisory votes on executive compensation occur annually. The '1 Year' option received 479,944,774 votes.

Yes, two shareholder proposals were not approved. These included a proposal for shareholder ratification of termination pay and a proposal requesting maternal morbidity reduction metrics in executive compensation.